Molecular Diagnostics: Page 2

HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
BillionToOne secures $140M financing agreement with Oberland Capital
By LabPulse.com staff writers
Molecular diagnostics firm BillionToOne has signed a $140 million nondilutive financing agreement with Oberland Capital Management.
September 5, 2024
Genetics Dna Money Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Upcoming lung cancer molecular testing guidelines address 7 questions
By Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Lung Cancer Hotspot Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
Scale Bio launches 100M cell challenge research initiative
By LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
Single Cell Analysis Social
CDC, WHO update on mpox outbreak
By LabPulse.com staff writers
The Centers for Disease Control and Prevention (CDC) recommended clinicians and jurisdictions in the U.S. maintain a heightened index of suspicion for monkeypox (mpox).
August 14, 2024
CDC mpox data, cases reported to the CDC as of August 1, 2024. (Source: U.S. CDC)
Oxford Nanopore to collaborate on Singapore's national sequencing initiative
By LabPulse.com staff writers
Oxford Nanopore will participate in Singapore's National Precision Medicine program, which is aimed at developing a comprehensive genetic catalog of the country's population.
August 6, 2024
Genome Sequence Barcode Social
Diagnostic laboratory joint venture expands RNA sequencing at Baylor
By LabPulse.com staff writers
WT RNAseq goes beyond the interpretation of already identified variants by whole exome sequencing (WES) or whole genome sequencing (WGS), according to Baylor Genetics.
August 6, 2024
Sequencing Dna Rna Social (1)
Labcorp gets FDA de novo authorization for solid tumor mutation liquid biopsy test
By LabPulse.com staff writers
Labcorp has received de novo marketing authorization from the U.S. Food and Drug Administration (FDA) for its PGDx Elio Plasma Focus Dx kitted assay, a pan-solid tumor liquid biopsy test that enables tumor mutation profiling.
August 5, 2024
Fda Button Social
Mercy Bioanalytics wins Disruptive Technology Award competition at ADLM 2024
By LabPulse.com staff writers
Cancer diagnostics company Mercy Bioanalytics won the Disruptive Technology Award Competition for its blood-based cancer screening technology at the Association for Diagnostics & Laboratory Medicine's (ADLM) annual meeting in Chicago on July 30.
July 30, 2024
Ovarian Cancer Social
Previous Page
Page 2 of 197
Next Page